Lipids
Research Areas
- Acyl-CoAs(12)
- Cyclooxygenase(517)
- Endocannabinoid/Endocannabinoid-like(141)
- Fatty Acid Conjugates(10)
- Fatty Acids(482)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(65)
- Fatty Esters/Ethers(146)
- Glycerolipids(352)
- Glycerophospholipids(239)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(138)
- Isoprostanes(35)
- Leukotrienes(61)
- Lipid Transport(8)
- Lipid-Based Drug Delivery(181)
- Octadecanoids(116)
- Other Lipid Kinases(2)
- P450(412)
- Polyketides(37)
- Prenol Lipids(19)
- Prostaglandins(462)
- Protein Lipidation(22)
- Reactive O2/N2 Pathways(113)
- Saccharolipids(1)
- Sphingolipids(340)
- Sterol Lipids(258)
- Thromboxanes(13)
- Lipoxins/Resolvin Es(10)
- 11β-HSD(1)
- 17β-HSD(3)
Products Related to Lipids(470)
- GC4120614(S)-HDHACAS: 119433-37-3Purity: >98.00%
14(S)-HDHA (14(S)-HDoHE) ist ein Oxygenierungsprodukt der DocosahexaensÄure (DHA).
- GC4120717(R)-HDHACAS: 155976-53-7Purity: >98.00%
Resolvins are a group of polyhydroxylated metabolites of docosahexaenoic acid (DHA) found in the inflammatory exudates of aspirin-treated experimental animals.
- GC4120917-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic AcidCAS: 1233715-33-7Purity: >98%
Docosapentaenoic acid (DPA) is a ω-3 fatty acid found in fish oils.
- GC41212(±)10(11)-EpDPACAS: 895127-65-8Purity: >95.00%
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers.
- GC41213(±)10-HDHACAS: 90780-50-0Purity: >98.00%
(±)10-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.
- GC41214(±)11-HDHACAS: 87018-59-5Purity: >98.00%
(±)11-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.
- GC4122615(S)-acetate Prostaglandin A2 methyl esterCAS: 36323-03-2Purity: >95.00%
15(S)-acetate Prostaglandin A2 methyl ester is a 15-acetylated derivative of prostaglandin A2 methyl ester.
- GC4122717(R)-Resolvin D1 methyl esterCAS: 937738-64-2Purity: >95.00%
17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM).
- GC41230Resolvin D1 methyl esterCAS: 937738-63-1Purity: >97.00%
Resolvin D1-Methylester (RvD1-Methylester) ist der Methylester von Resolvin D1.
- GC41231Resolvin D2 methyl esterCAS: 810668-53-2Purity: >95.00%
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase.
- GC41232Resolvin D3 methyl esterPurity: >95.00%
Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties.
- GC41262(±)-α-CMBHCCAS: 7083-09-2Purity: >98.00%
Vitamin E is a well known antioxidant that exists in eight natural forms: four tocopherols (α, β, δ, and γ) and four tocotrienols (α, β, δ, and γ).
- GC4130017β-hydroxy ExemestaneCAS: 122370-91-6Purity: >98.00%
17β-hydroxy Exemestane is the primary active metabolite of exemestane.
- GC4132014,15-Leukotriene A4 methyl esterCAS: 75290-58-3Purity: >95.00%
14,15-Leukotriene A4 (14,15-LTA4) methyl ester is an esterified form of 14,15-LTA4, a leukotriene isomer formed from arachidonic acid by 15-lipoxygenase (15-LO) that inhibits LTA4 hydrolase.
- GC4138720-hydroxy Arachidic AcidCAS: 62643-46-3Purity: >98.00%
20-hydroxy Arachidic acid is a hydroxylated fatty acid that has been found in the suberin component of silver birch (B.
- GC4152917-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic AcidCAS: 1233715-28-0Purity: >90.00%
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity.
- GC415304-oxo Docosahexaenoic AcidCAS: 845673-74-7Purity: >90.00%
4-oxo Docosahexaenoic acid (4-oxo DHA) is a putative metabolite of DHA with antiproliferative and PPARγ agonist activity.
- GC41575N-3-hydroxyoctanoyl-L-Homoserine lactoneCAS: 192883-14-0Purity: >98.00%
Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density.
- GC41648(±)13(14)-DiHDPACAS: 1345275-24-2Purity: >98.00%
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases.
- GC41653(±)16(17)-DiHDPACAS: 1345275-27-5Purity: >95.00%
(±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid.
- GC41654(±)19(20)-DiHDPAPurity: >98.00%
Docosahexaenoic acid is an essential fatty acid and the most abundant ω-3 fatty acid in neural tissues, especially in the retina and brain.
- GC41655(±)19(20)-EDP EthanolamideCAS: 2123485-34-5Purity: >98.00%
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively).
- GC41660(±)4(5)-EpDPA methyl esterCAS: 121818-29-9Purity: >98.00%
(±)4(5)-EpDPA methyl ester is a derivative of (±)4(5)-EpDPA which is stable enough to ship and handle routinely.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC41206 | 14(S)-HDHA | 119433-37-3 | >98.00% | |
14(S)-HDHA (14(S)-HDoHE) ist ein Oxygenierungsprodukt der DocosahexaensÄure (DHA). | ||||
| GC41207 | 17(R)-HDHA | 155976-53-7 | >98.00% | |
Resolvins are a group of polyhydroxylated metabolites of docosahexaenoic acid (DHA) found in the inflammatory exudates of aspirin-treated experimental animals. | ||||
| GC41209 | 17-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid | 1233715-33-7 | >98% | |
Docosapentaenoic acid (DPA) is a ω-3 fatty acid found in fish oils. | ||||
| GC41210 | 22-HDHA | 90780-46-4 | >95.00% | |
22-HDHA is an oxidation product of docosahexaenoic acid. | ||||
| GC41212 | (±)10(11)-EpDPA | 895127-65-8 | >95.00% | |
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. | ||||
| GC41213 | (±)10-HDHA | 90780-50-0 | >98.00% | |
(±)10-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. | ||||
| GC41214 | (±)11-HDHA | 87018-59-5 | >98.00% | |
(±)11-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. | ||||
| GC41226 | 15(S)-acetate Prostaglandin A2 methyl ester | 36323-03-2 | >95.00% | |
15(S)-acetate Prostaglandin A2 methyl ester is a 15-acetylated derivative of prostaglandin A2 methyl ester. | ||||
| GC41227 | 17(R)-Resolvin D1 methyl ester | 937738-64-2 | >95.00% | |
17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM). | ||||
| GC41230 | Resolvin D1 methyl ester | 937738-63-1 | >97.00% | |
Resolvin D1-Methylester (RvD1-Methylester) ist der Methylester von Resolvin D1. | ||||
| GC41231 | Resolvin D2 methyl ester | 810668-53-2 | >95.00% | |
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase. | ||||
| GC41232 | Resolvin D3 methyl ester | - | >95.00% | |
Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. | ||||
| GC41262 | (±)-α-CMBHC | 7083-09-2 | >98.00% | |
Vitamin E is a well known antioxidant that exists in eight natural forms: four tocopherols (α, β, δ, and γ) and four tocotrienols (α, β, δ, and γ). | ||||
| GC41300 | 17β-hydroxy Exemestane | 122370-91-6 | >98.00% | |
17β-hydroxy Exemestane is the primary active metabolite of exemestane. | ||||
| GC41320 | 14,15-Leukotriene A4 methyl ester | 75290-58-3 | >95.00% | |
14,15-Leukotriene A4 (14,15-LTA4) methyl ester is an esterified form of 14,15-LTA4, a leukotriene isomer formed from arachidonic acid by 15-lipoxygenase (15-LO) that inhibits LTA4 hydrolase. | ||||
| GC41387 | 20-hydroxy Arachidic Acid | 62643-46-3 | >98.00% | |
20-hydroxy Arachidic acid is a hydroxylated fatty acid that has been found in the suberin component of silver birch (B. | ||||
| GC41529 | 17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid | 1233715-28-0 | >90.00% | |
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity. | ||||
| GC41530 | 4-oxo Docosahexaenoic Acid | 845673-74-7 | >90.00% | |
4-oxo Docosahexaenoic acid (4-oxo DHA) is a putative metabolite of DHA with antiproliferative and PPARγ agonist activity. | ||||
| GC41575 | N-3-hydroxyoctanoyl-L-Homoserine lactone | 192883-14-0 | >98.00% | |
Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density. | ||||
| GC41648 | (±)13(14)-DiHDPA | 1345275-24-2 | >98.00% | |
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. | ||||
| GC41653 | (±)16(17)-DiHDPA | 1345275-27-5 | >95.00% | |
(±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid. | ||||
| GC41654 | (±)19(20)-DiHDPA | - | >98.00% | |
Docosahexaenoic acid is an essential fatty acid and the most abundant ω-3 fatty acid in neural tissues, especially in the retina and brain. | ||||
| GC41655 | (±)19(20)-EDP Ethanolamide | 2123485-34-5 | >98.00% | |
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). | ||||
| GC41660 | (±)4(5)-EpDPA methyl ester | 121818-29-9 | >98.00% | |
(±)4(5)-EpDPA methyl ester is a derivative of (±)4(5)-EpDPA which is stable enough to ship and handle routinely. | ||||
